Connect with us at ASHG in Boston!
October 14–18, 2025
Turning Samples Into Insights
From data generation to breakthrough discoveries—we help you transform every sample into actionable insights.
Beyond Sequencing. Scientific Solutions.
Broad Clinical labs utilizes the latest multi-omic sequencing technologies and analytical tools to deliver publication-ready data you can trust, empowering you with new insights that drive your discovery and clinical research forward. Our comprehensive suite of services spans large-scale genomic discovery through targeted clinical applications, delivering end-to-end solutions that bridge research and patient care.
Whether you’re conducting GWAS studies, clinical trials, or translational research, we transform your samples into the high-quality datasets that accelerate discovery and advance patient care.

Meet our Team at the ASHG Annual Meeting!
Let’s discuss solutions for your clinical research.
We’re excited that this year’s ASHG conference is located right here in Boston! There are several ways to engage with our team of experts at the conference:
Visit us in booth #659
Visit our Posters at ASHG
Enabling Ultra-Rapid Clinical Whole Genome Sequencing for Same-Day Return of Results
- Michelle Cipicchio
- Wednesday, October 15
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
Efficient full-length RNA single-cell isoform sequencing using Sequencing by Expansion
- Christophe Georgescu
- Thursday, October 16
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
Leveraging Constellation Mapped Read Technology for Variant Detection in Complex, Medically Relevant Genes
- Katie Larkin
- Thursday, October 16
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
Single-Cell Multi-Omic Drug Response Profiling of 1 Million Cells Across 500 PRISM-Multiplexed Cancer Cell Lines sequenced with SBX
- Houlin Yu
- Thursday, October 16
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
The impact of RNA quality on isoform and fusion detection by long-read sequencing
- Allison Brookhart
- Thursday, October 16
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
Evaluating Whole-Genome Sequencing as a Viable Replacement for Chromosomal Microarray Using the DRAGEN v4.4 Cytogenetics Module
- Yueyao Gao
- Friday, October 17
- 2:30–4:30 PM EDT
- Exhibit & Poster Hall, Lower Level
- Poster #TBD
Attend our Presentations at ASHG
Session 79 - Genetic Landscapes: Innovations in Population Genetics, Epidemiology, and Genomic Tools
Lightning Talk
- Friday, October 17
- 1:30–2:30pm ET
- Houlin Yu
-
Room 258ABC/Level 2
Thomas Michael Menino Convention & Exhibition Center
Why Leading Researchers Choose Broad Clinical Labs
At Broad Clinical Labs, we believe that researchers deserve access to affordable, high-precision multi-omics services that never compromise on quality. For over 30 years we have helped clinical researchers around the world to identify clinical biomarkers, de-risk clinical development, improve patient stratification, and increase clinical trial success rates.
Speed & Scalability
BCL’s streamlined sample-to-insights workflow and scalable, high-throughput capabilities support rapid turnaround of high-quality data.
Scientific Excellence
BCL’s expert PhD-level scientific team, CLIA-licensed and CAP-accredited facilities, and rigorous quality control practices produce publication-ready data that stands up to peer-review.
Expert Partnership
BCL provides collaborative study design consultation, access to state-of-the-art analytical pipelines, full visibility to project status, and ongoing support to help you answer your specific research questions.
Data-Driven Outcomes
BCL‘s comprehensive quality metrics ensure delivery of validated datasets suitable for inclusion in regulatory submissions, grant applications, and publications.
Explore world-class services made accessible to researchers everywhere.
Join a Community at the Forefront of Discovery
Our leading clinical research network extends well beyond the Boston Biotech Corridor to include partners from around the world. Through collaboration, we are making significant strides in understanding the molecular origins of disease and improving human health.






Read our blog to learn how, together, we are shaping the future of clinical genomics.